Cargando…
Human monoclonal antibodies as candidate therapeutics against emerging viruses and HIV-1
More than 40 monoclonal antibodies (mAbs) have been approved for a number of disease indications with only one of these (Synagis) — for a viral disease, and not for therapy but for prevention. However, in the last decade novel potent mAbs have been discovered and characterized with potential as ther...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
SP Wuhan Institute of Virology, CAS
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7090799/ https://www.ncbi.nlm.nih.gov/pubmed/23575729 http://dx.doi.org/10.1007/s12250-013-3313-x |